(Press-News.org) In a study that included nearly 14,000 patients with rheumatoid arthritis or psoriasis, the use of certain disease-modifying antirheumatic drugs was found to lower the risk of diabetes, according to a study in the June 22/29 issue of JAMA.
Two common systemic inflammatory conditions, rheumatoid arthritis (RA) and psoriasis, predispose patients to insulin resistance and may place patients at risk for diabetes mellitus (DM). The treatment of psoriasis and RA includes disease-modifying antirheumatic drugs (DMARDs) such as tumor necrosis factor (TNF) inhibitors, which are directed against the inflammatory response, according to background information in the article. The relationship between these conditions and DM suggests that systemic immunosuppression may also reduce the risk for DM.
Daniel H. Solomon, M.D., M.P.H., of Brigham and Women's Hospital, Boston, and colleagues examined the relationship between DMARD medications and the risk of newly diagnosed DM among participants with RA or psoriasis. The researchers conducted a retrospective cohort study among 121,280 patients with a diagnosis of either RA or psoriasis on at least 2 visits. The analyses were conducted in the context of 2 large health insurance programs, 1 in Canada and 1 in the United States, using administrative data. The average follow-up was 5.8 months and began with the first prescription for a DMARD after study eligibility was met. Drug regimens were categorized into 4 mutually exclusive groups: (1) TNF inhibitors with or without other DMARDs; (2) methotrexate without TNF inhibitors or hydroxychloroquine; (3) hydroxychloroquine without TNF inhibitors or methotrexate; or (4) other nonbiologic DMARDs without TNF inhibitors, methotrexate, or hydroxychloroquine.
The final study cohort consisted of 13,905 participants with 22,493 new treatment episodes starting 1 of the categories of DMARD regimens between January 1996 and June 2008. The researchers found 267 newly diagnosed cases of DM: 55 cases among 3,993 treatment episodes with nonbiologic DMARD users; 80 cases among 4,623 treatment episodes with TNF inhibitor users; 82 cases among 8,195 treatment episodes with methotrexate users; and 50 cases among 5,682 treatment episodes with hydroxychloroquine users. The incidence rates for DM were highest for individuals who switched to other nonbiologic DMARDs and lowest for TNF inhibitor users. "The fully adjusted models suggest a reduced relative risk of DM for TNF inhibitor and hydroxychloroquine compared with other nonbiologic DMARDs," the authors write.
According to the authors, "The findings from this epidemiologic study should be considered hypothesis-generating. However, considering these results in light of prior findings regarding improved insulin and glucose metabolism and reduced DM risk with hydroxychloroquine and TNF inhibitors, there is evidence suggesting a possible role for DMARDs and immunosuppression in DM prevention. A randomized controlled trial testing the ability of these agents to prevent DM among participants with systemic inflammatory disorders should be considered."
(JAMA. 2011;305[24]2525-2531. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Can Treatment of Chronic Inflammatory Diseases Reduce the Risk of Diabetes Mellitus?
In an accompanying editorial, Tim Bongartz, M.D., M.S., and Yogish Kudva, M.D., of the Mayo Clinic College of Medicine, Rochester, Minn., comment on the findings of this study.
"Prospective trials are needed to confirm the observational data and clarify which patients may benefit from these possible [multiple] effects of specific anti-inflammatories. If hydroxychloroquine and anti-TNF agents should truly enable 2 complex disease processes to be addressed with a single intervention, it will be crucial to investigate how much of their potential antidiabetic effects would add to good disease control, the durability of these effects, and the timing of treatment. Because even if treatment of chronic inflammatory disease can reduce the risk of diabetes, clinicians still will have to learn how to use specific anti-inflammatory agents to achieve optimal outcomes for both conditions."
(JAMA. 2011;305[24]2573-2574. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including financial disclosures, funding and support, etc.
###
To contact Daniel H. Solomon, M.D., M.P.H., call Lori Shanks at 617-534-1604 or email ljshanks@partners.org. To contact editorial co-author Tim Bongartz, M.D., M.S., call Sharon Theimer at 507-284-5005 or email theimer.sharon@mayo.edu.
END
Boston, MA – A new study from Harvard School of Public Health (HSPH) and University of California, San Francisco, researchers suggests that men with prostate cancer who smoke increase their risk of prostate cancer recurrence and of dying from the disease. A link also was found between smoking at the time of prostate cancer diagnosis and aggressive prostate cancer, overall mortality (death) and cardiovascular disease mortality.
"In our study, we found similar results for both prostate cancer recurrence and prostate cancer mortality," said Stacey Kenfield, lead author ...
This year, in the case of McDonald v City of Chicago, the Supreme Court ruled that the Second Amendment extends throughout the United States and protects gun owners in every state and municipality. The Court unequivocally affirmed an individual's right to own handguns for self-defense. While gun-control laws may still be legal, the Court has also effectively prohibited states and localities from complete bans on gun ownership. In short, gun control efforts will be subjected to constitutional scrutiny and analysis. If restrictions go too far, courts are likely to find such ...
Diabetic kidney disease has become more prevalent in the United States over the past 20 years, despite a substantial increase in the use of medications for the treatment of people with diabetes, according to a study to be published June 22 in JAMA, the Journal of the American Medical Association.
These medications include drugs that lower glucose, blood pressure and lipids.
The widespread application of medications proven to improve health in clinical trials has markedly bettered the control of blood sugar, blood pressure, and cholesterol in the diabetic population ...
After two days of testimony by members of the Drug Enforcement Administration (DEA) and the United States Marshals Service (USMS), the United States District Court in Detroit granted the defendant's motion to dismiss the indictment, and immediately released Jesus Manuel Caro-Villalobos of Silt, Colorado, from custody. The Court ruled that the government clearly violated Mr. Caro's constitutional right to a speedy-trial. See U.S. v. Caro-Villalobos, EDMI, # 00-80572.
Regarding the Court's decision, Mr. Caro's attorney, former federal prosecutor John Freeman of Troy, remarked, ...
Researchers in Australia have discovered that mothers who smoke during pregnancy are causing developmental changes to their unborn babies that lead to them having lower levels of the type of cholesterol that is known to protect against heart disease in later life – high-density lipoprotein (HDL) cholesterol.
The research, published online today in the European Heart Journal [1], showed that, by the age of eight years, children born to mothers who smoked while they were pregnant had HDL cholesterol levels of about 1.3 millimoles per litre (mmol/L), compared to the more ...
Every year more than 20,000 people in Indiana sustain a traumatic brain injury (TBI). Nationwide, about one million people experience a TBI each year. Medical advancements have reduced fatalities from brain injuries, but as a result many people are now living with disabilities stemming from brain injuries.
A TBI is defined by the Center for Disease Control and Prevention (CDC) as an injury that occurs when "impact to the head results in disruption of brain functioning." There are a variety of causes of TBI, with motor vehicle accidents being one of the most common. ...
Using barium oxide nanoparticles, researchers have developed a self-cleaning technique that could allow solid oxide fuel cells to be powered directly by coal gas at operating temperatures as low as 750 degrees Celsius. The technique could provide a cleaner and more efficient alternative to conventional power plants for generating electricity from the nation's vast coal reserves.
Solid oxide fuel cells can operate on a wide variety of fuels, and use hydrocarbons gases directly – without a separate reformer. The fuel cells rely on anodes made from nickel and a ceramic ...
Thousands of patients in Scotland who are particularly vulnerable to adverse drug events (ADEs) were prescribed high-risk medications by their GPs which could potentially cause them harm, according to research published on BMJ.com today.
Although at least some of this prescribing will be appropriate because prescribers and patients are balancing risks and benefits when there may be no clearly 'correct' course of action, the study also finds that there was significant variation in the prescribing practices between the GPs surgeries surveyed. This variation could not ...
BOSTON, MA – Individuals with systemic inflammatory conditions, such as rheumatoid arthritis (RA) and psoriasis, experience a 1.5 to 2-fold increased rate of cardiovascular disease. Previous research suggests that inflammation and insulin resistance, linked with these conditions, likely accelerate the development of cardiovascular risk and diabetes. Researchers at Brigham and Women's Hospital (BWH) sought to determine whether commonly used disease-modifying antirheumatic drugs (DMARDs), which are directed against inflammation, might reduce the risk for developing diabetes ...
When people hear the term "mild brain injury" they may assume that such an injury is not that serious. The basic misunderstanding stems from the fact that "mild" is used to indicate to neurosurgeons that the injury is not life-threatening and does not require emergent surgery. "Mild" does not intend to describe the seriousness of the consequences resulting from the injury. In fact, a mild traumatic brain injury can potentially cause serious and long-term damage to the functioning of an individual's brain.
What is a Mild Brain Injury?
A ...
